Nanotechnology News and Research

RSS

Scientist sheds new light on cellular basis of neural impulse transmission

Neural impulse transmission and its effects on the functioning of the central nervous system (CNS) and peripheral nervous system (PNS) have always been in the forefront of discussion and studies, in the field of memory and behavioural changes.

8 Nov 2010

Spectrum Pharmaceuticals receives $977,900 grant under QTDP program

Spectrum Pharmaceuticals, Inc. a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has been awarded grants totaling $977,900 under the Qualifying Therapeutic Discovery Project (QTDP) Program administered under section 48D of the Internal Revenue Code.

4 Nov 2010

New mathematical modeling shows cellular basis of neural transmission

NJIT Associate Professor Victor Matveev, PhD, in the department of mathematical sciences, was part of a research team that published "N-type Ca2+ channels carry the largest current: Implications for nanodomains and transmitter release," in Nature Neuroscience on Oct. 17, 2010.

3 Nov 2010

Novel technology using quantum dots increases drug uptake in lung injury

Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.

2 Nov 2010

New microfluidic in vitro kinase radioassay improves efficiency to detect cancer growth

Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity.

2 Nov 2010

GlycosBio, Malaysian Bio-XCell enter agreement to build biochemical plant and biotechnology R&D facility

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today exchanged definitive agreements with Malaysian Bio-XCell for the establishment of the Company's industrial biochemical plant and biotechnology R&D facility in Malaysia

1 Nov 2010

New solvent system could provide ways of producing nanometer-scale cancer chemotherapy agents

Noble metals such as platinum and palladium are becoming increasingly important because of growth in environmentally friendly applications such as fuel cells and pollution control catalysts. But the world has limited quantities of these materials, meaning manufacturers will have to rely on efficient recycling processes to help meet the demand.

29 Oct 2010

Malvern Zetasizer Nano used to characterize environmentally responsive nanoparticles

The rapid, real-time measurement capabilities of the Zetasizer Nano system from Malvern Panalytical have enabled quantified nanoscale characterization of the environmental sensitivity of novel solubilization nanoparticles.

From Malvern Panalytical 28 Oct 2010

Unidym, NanoIntegris enter distribution agreement for HiPco carbon nanotube products

Unidym a majority owned subsidiary of Arrowhead Research announced today that it entered into a partnership with NanoIntegris, Inc., an Illinois-based supplier of carbon nanotubes. Effective October 27, 2010, NanoIntegris will distribute HiPco carbon nanotube products. HiPco nanotubes are valued by customers due to their small diameter range, ease of optical imaging, ease of chemical functionalization, compatibility with high frequency fiber optics research, and good batch to batch consistency.

28 Oct 2010

Lumiphore signs global cooperation with Algeta to integrate Lumi4 complexes

Lumiphore Inc., a portfolio company of Nanostart AG, has signed a global cooperation with Algeta ASA a leading company specializing in innovative radiopharmaceutical therapies to treat cancer patients. The agreement enables the integration of Lumiphore's Lumi4 complexes into the targeted radiotherapeutics and companion diagnostics from Algeta.

From Thermo Fisher Scientific Inc. 26 Oct 2010

New source of blood-derived biomarkers may help in cancer diagnosis

The future of cancer diagnosis may lie in just a few milliliters of blood, according to a research team led by Professor Arie Admon of the Technion-Israel Institute of Technology.

26 Oct 2010

Kanto Chemical to distribute NanoIntegris' carbon nanotubes in Japan

NanoIntegris, Inc. announced today that it entered into a distribution contract with Kanto Chemical Co., Inc. NanoIntegris is the world's only supplier of 99% enriched metallic and semiconducting single-walled carbon nanotubes. Research companies and universities are currently using NanoIntegris' carbon nanotubes to develop emerging technologies such as printable transistors, chemical sensors, and biomedical applications such as imaging and drug delivery.

25 Oct 2010

Shrink announces agreement to produce high content screening tool for biotech R&D subsidiary

Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.

25 Oct 2010

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Researchers from Rice University's Laboratory for Nanophotonics (LANP), the radiology department at Baylor College of Medicine (BCM) and the University of Texas MD Anderson Cancer Center are preparing to test a combined approach for diagnosing and treating pancreatic cancer with a specially engineered nanoparticle.

19 Oct 2010

Nanotope enters agreement with Smith & Nephew to develop cartilage regeneration product

Arrowhead Research Corporation today announced that its portfolio company, Nanotope, Inc., has entered into an agreement with Smith & Nephew, Inc., a member of the Smith & Nephew plc group to develop a cartilage regeneration product for human healthcare markets using a subset of its proprietary regenerative medicine technology.

18 Oct 2010

NanoViricides' President delivers speech at ASNM Second Annual Conference

NanoViricides, Inc. announced today that the Company President was invited to and presented a talk at the Second Annual Conference of the American Society for NanoMedicine (ASNM).

18 Oct 2010

Shrink reveals image of StemDisc450 biomedical research tool

Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.

18 Oct 2010

Silver studded bacteria could help treat common cold and flu

Finally scientists may have found a potential cure for common cold. They have found “silver bullets” in yogurt that could destroy viruses and provide a cure for the flu and common cold.

18 Oct 2010

New, affordable technology for cervical cancer screening

Current cervical cancer screening is time consuming and expensive, but now new breakthrough technology developed by European researchers should allow large-range screening by non-medical personnel with almost immediate results and at a much lower cost.

15 Oct 2010

Stony Brook professor receives 2010 NIH Director's New Innovator Award

Balaji Sitharaman, Ph.D., Assistant Professor of Biomedical Engineering at Stony Brook University, is a 2010 recipient of the National Institutes of Health (NIH) Director's New Innovator Award.

14 Oct 2010

Nanotechnology News and Research

Scientist sheds new light on cellular basis of neural impulse transmission

Spectrum Pharmaceuticals receives $977,900 grant under QTDP program

New mathematical modeling shows cellular basis of neural transmission

Novel technology using quantum dots increases drug uptake in lung injury

New microfluidic in vitro kinase radioassay improves efficiency to detect cancer growth

GlycosBio, Malaysian Bio-XCell enter agreement to build biochemical plant and biotechnology R&D facility

New solvent system could provide ways of producing nanometer-scale cancer chemotherapy agents

Malvern Zetasizer Nano used to characterize environmentally responsive nanoparticles

Unidym, NanoIntegris enter distribution agreement for HiPco carbon nanotube products

Lumiphore signs global cooperation with Algeta to integrate Lumi4 complexes

New source of blood-derived biomarkers may help in cancer diagnosis

Kanto Chemical to distribute NanoIntegris' carbon nanotubes in Japan

Shrink announces agreement to produce high content screening tool for biotech R&D subsidiary

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Nanotope enters agreement with Smith & Nephew to develop cartilage regeneration product

NanoViricides' President delivers speech at ASNM Second Annual Conference

Shrink reveals image of StemDisc450 biomedical research tool

Silver studded bacteria could help treat common cold and flu

New, affordable technology for cervical cancer screening

Stony Brook professor receives 2010 NIH Director's New Innovator Award

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News